|
22 Companies |
|
16 Products |
|
16 Products |
|
10 Mechanisms of Action |
|
3 Trials |
|
538 News |
|
| 123456789101112» |
- | Phase classification, Enrollment change: Over-arousal as a Mechanism Between Alcohol and Intimate Partner Violence (clinicaltrials.gov) - Oct 15, 2024
P1, N=42, Completed, Sponsor: University of New Mexico
Phase classification: P=N/A --> P1 | N=170 --> 42
- | NN1213 / Novo Nordisk
Enrollment change: ARCH Research Protocol for Provider Alcohol Pharmacotherapy Training and Assessment (clinicaltrials.gov) - Jun 3, 2024
P=N/A, N=117, Completed, Sponsor: University of Alabama at Birmingham
Phase classification: P=N/A --> P1 | N=170 --> 42 N=236 --> 117
- | NN1213 / Novo Nordisk
Phase classification: Transcranial Magnetic Stimulation in Alcohol Use Disorder (clinicaltrials.gov) - Feb 15, 2024
P=N/A, N=14, Completed, Sponsor: Catholic University of the Sacred Heart
N=236 --> 117 Phase classification: P3 --> P=N/A
- | Enrollment change, Trial withdrawal: Alcohol Use and Sexual Risk: An Intervention (clinicaltrials.gov) - Jan 11, 2024
P=N/A, N=0, Withdrawn, Sponsor: University of New Mexico
Phase classification: P3 --> P=N/A N=484 --> 0 | Completed --> Withdrawn
- | NN1213 / Novo Nordisk
Trial completion: Motivational Interviewing and Culture for Urban Native American Youth (MICUNAY) (clinicaltrials.gov) - Apr 26, 2019
P=N/A, N=185, Completed, Sponsor: RAND
N=484 --> 0 | Completed --> Withdrawn Recruiting --> Completed
- | Enrollment change: ADVISE: Alcohol Drinking as a Vital Sign (clinicaltrials.gov) - Apr 24, 2019
P=N/A, N=639613, Completed, Sponsor: Kaiser Permanente
Recruiting --> Completed N=466000 --> 639613
- | NN1213 / Novo Nordisk
Trial completion: CTMI: A Randomized Clinical Trial of Culturally Tailored MI (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=301, Completed, Sponsor: Northeastern University
N=466000 --> 639613 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change: Mindfulness-Based Relapse Prevention for Alcohol Use Disorders in Remission (clinicaltrials.gov) - Apr 19, 2019
P=N/A, N=4, Completed, Sponsor: University of Virginia
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=104 --> 4
- | Trial completion: ADVISE: Alcohol Drinking as a Vital Sign (clinicaltrials.gov) - Mar 13, 2019
P=N/A, N=466000, Completed, Sponsor: Kaiser Permanente
Active, not recruiting --> Completed | N=104 --> 4 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Enrollment change, Trial completion date, Trial withdrawal, Trial primary completion date: Oxytocin in Alcohol Use Disorder (clinicaltrials.gov) - Feb 26, 2019
P1, N=0, Withdrawn, Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Active, not recruiting --> Completed N=32 --> 0 | Trial completion date: Nov 2019 --> Feb 2019 | Not yet recruiting --> Withdrawn | Trial primary completion date: Nov 2019 --> Feb 2019
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date, Surgery: STOP-OP: Intensive Smoking and Alcohol Cessation Intervention in Bladder Cancer Surgery Patients (clinicaltrials.gov) - Feb 4, 2019
P=N/A, N=105, Completed, Sponsor: Rigshospitalet, Denmark
N=32 --> 0 | Trial completion date: Nov 2019 --> Feb 2019 | Not yet recruiting --> Withdrawn | Trial primary completion date: Nov 2019 --> Feb 2019 Recruiting --> Completed | Trial completion date: Mar 2018 --> Jul 2018 | Trial primary completion date: Mar 2018 --> Jul 2018
- | Trial completion, Phase classification: Melatonin Use for Sleep Problems in Alcohol Dependent Patients (clinicaltrials.gov) - Feb 4, 2019
P2, N=60, Completed, Sponsor: Centre for Addiction and Mental Health
Recruiting --> Completed | Trial completion date: Mar 2018 --> Jul 2018 | Trial primary completion date: Mar 2018 --> Jul 2018 Recruiting --> Completed | Phase classification: PN/A --> P2
- | NN1213 / Novo Nordisk
Trial completion date: Computerized Tool for Preventing Prenatal Drinking (clinicaltrials.gov) - Jan 23, 2019
P=N/A, N=185, Completed, Sponsor: Public Health Institute, California
Recruiting --> Completed | Phase classification: PN/A --> P2 Trial completion date: Aug 2017 --> Aug 2018
- | Trial completion, Enrollment change, Trial initiation date: Over-arousal as a Mechanism Between Alcohol and Intimate Partner Violence (clinicaltrials.gov) - Jan 8, 2019
P=N/A, N=170, Completed, Sponsor: University of New Mexico
Trial completion date: Aug 2017 --> Aug 2018 Recruiting --> Completed | N=70 --> 170 | Initiation date: Mar 2015 --> Sep 2015
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: AABM to Decrease Problem Drinking and Impulsivity in Veterans With AUD: A Pilot Study (clinicaltrials.gov) - Dec 21, 2018
P=N/A, N=32, Completed, Sponsor: University of California, San Francisco
Recruiting --> Completed | N=70 --> 170 | Initiation date: Mar 2015 --> Sep 2015 Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Feb 2018 | Trial primary completion date: Jun 2018 --> Feb 2018
- | NN1213 / Novo Nordisk
Trial primary completion date: Oxytocin in Alcohol Use Disorder (clinicaltrials.gov) - Dec 10, 2018
P1, N=32, Not yet recruiting, Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Feb 2018 | Trial primary completion date: Jun 2018 --> Feb 2018 Trial primary completion date: Nov 2018 --> Nov 2019
- | NN1213 / Novo Nordisk
Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Young Adult Naturalistic Alcohol Study (YANAS) Using Smartphone Technology in a Simulated Laboratory Environment (clinicaltrials.gov) - Dec 3, 2018
P=N/A, N=9, Terminated, Sponsor: University of Florida
Trial primary completion date: Nov 2018 --> Nov 2019 N=129 --> 9 | Trial completion date: Dec 2018 --> Feb 2018 | Recruiting --> Terminated | Trial primary completion date: Dec 2018 --> Feb 2018; Protocol expired with IRB.
- | NN1213 / Novo Nordisk
Trial completion: A Clinical Trial of SBIRT Services in School-based Health Centers (clinicaltrials.gov) - Nov 15, 2018
P=N/A, N=300, Completed, Sponsor: Friends Research Institute, Inc.
N=129 --> 9 | Trial completion date: Dec 2018 --> Feb 2018 | Recruiting --> Terminated | Trial primary completion date: Dec 2018 --> Feb 2018; Protocol expired with IRB. Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Zinc for HIV Disease Among Alcohol Users - an RCT in the Russia ARCH Cohort (clinicaltrials.gov) - Nov 9, 2018
P=N/A, N=254, Completed, Sponsor: Boston Medical Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: REDART: Reducing Hazardous Alcohol Use & Human Immunodeficiency Virus (HIV) Viral Load (clinicaltrials.gov) - Oct 12, 2018
P=N/A, N=441, Completed, Sponsor: University of North Carolina, Chapel Hill
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial completion date, Head-to-Head: EFAR-Spain: Primary Care-based Facilitated Access to a Web Based Brief Intervention to Reduce Alcohol Consumption (clinicaltrials.gov) - Aug 17, 2018
P=N/A, N=320, Completed, Sponsor: Hospital Clinic of Barcelona
Active, not recruiting --> Completed Recruiting --> Completed | N=1000 --> 320 | Trial completion date: Dec 2018 --> Dec 2017
- | Trial completion: RRFT: Integrative Risk Reduction and Treatment for Teen Substance Use Problems and PTSD (clinicaltrials.gov) - Aug 3, 2018
P=N/A, N=135, Completed, Sponsor: Medical University of South Carolina
Recruiting --> Completed | N=1000 --> 320 | Trial completion date: Dec 2018 --> Dec 2017 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date: Brief Alcohol Intervention for Adolescents Who Have Attempted Suicide (clinicaltrials.gov) - Jul 24, 2018
P1, N=50, Completed, Sponsor: Boston Children
Active, not recruiting --> Completed Recruiting --> Completed | Trial completion date: Sep 2018 --> May 2018
- | Phase classification: Remote Monitoring and Contingency Management Reinforcement for Alcohol Abstinence (clinicaltrials.gov) - Jul 20, 2018
P=N/A, N=30, Completed, Sponsor: UConn Health
Recruiting --> Completed | Trial completion date: Sep 2018 --> May 2018 Phase classification: P1 --> P=N/A
- | NN1213 / Novo Nordisk
Trial completion: ICT: Integrating Combined Therapies for Persons With Co-occurring Disorders (clinicaltrials.gov) - Jun 29, 2018
P=N/A, N=38, Completed, Sponsor: Stanford University
Phase classification: P1 --> P=N/A Enrolling by invitation --> Completed
- | NN1213 / Novo Nordisk
Enrollment closed, Trial completion date, Trial primary completion date: A Clinical Trial of SBIRT Services in School-based Health Centers (clinicaltrials.gov) - Jun 27, 2018
P=N/A, N=300, Active, not recruiting, Sponsor: Friends Research Institute, Inc.
Enrolling by invitation --> Completed Enrolling by invitation --> Active, not recruiting | Trial completion date: May 2018 --> Aug 2018 | Trial primary completion date: May 2018 --> Aug 2018
- | NN1213 / Novo Nordisk
Trial completion date: Zinc for HIV Disease Among Alcohol Users - an RCT in the Russia ARCH Cohort (clinicaltrials.gov) - Jun 21, 2018
P=N/A, N=254, Active, not recruiting, Sponsor: Boston Medical Center
Enrolling by invitation --> Active, not recruiting | Trial completion date: May 2018 --> Aug 2018 | Trial primary completion date: May 2018 --> Aug 2018 Trial completion date: Apr 2018 --> Oct 2018
- | Trial completion date, Trial primary completion date: RRFT: Integrative Risk Reduction and Treatment for Teen Substance Use Problems and PTSD (clinicaltrials.gov) - Jun 18, 2018
P=N/A, N=135, Active, not recruiting, Sponsor: Medical University of South Carolina
Trial completion date: Apr 2018 --> Oct 2018 Trial completion date: Jan 2018 --> Jul 2018 | Trial primary completion date: Jan 2018 --> Jun 2018
- | Trial termination, Trial primary completion date: Use of NAC in Prevention of Hangover Symptoms; Independent Alcohol Consumption Protocol (clinicaltrials.gov) - Jun 11, 2018
P=N/A, N=200, Terminated, Sponsor: St. Luke's Hospital and Health Network, Pennsylvania
Trial completion date: Jan 2018 --> Jul 2018 | Trial primary completion date: Jan 2018 --> Jun 2018 Recruiting --> Terminated | Trial primary completion date: Dec 2017 --> Jun 2018; unable to enroll sufficient number of participants
- | Chantix (varenicline) / Pfizer
Enrollment change, Trial withdrawal: Effects of Varenicline in Heavy Drinking Smokers (clinicaltrials.gov) - Jun 3, 2018
P4, N=0, Withdrawn, Sponsor: University of California, Los Angeles
Recruiting --> Terminated | Trial primary completion date: Dec 2017 --> Jun 2018; unable to enroll sufficient number of participants N=22 --> 0 | Not yet recruiting --> Withdrawn
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: Computerized Tool for Preventing Prenatal Drinking (clinicaltrials.gov) - Jun 1, 2018
P=N/A, N=185, Completed, Sponsor: Public Health Institute, California
N=22 --> 0 | Not yet recruiting --> Withdrawn Active, not recruiting --> Completed | Trial completion date: Aug 2018 --> Aug 2017 | Trial primary completion date: Aug 2018 --> Aug 2017
- | NN1213 / Novo Nordisk
Enrollment closed, Trial completion date, Trial primary completion date: AABM to Decrease Problem Drinking and Impulsivity in Veterans With AUD: A Pilot Study (clinicaltrials.gov) - May 30, 2018
P=N/A, N=32, Active, not recruiting, Sponsor: University of California, San Francisco
Active, not recruiting --> Completed | Trial completion date: Aug 2018 --> Aug 2017 | Trial primary completion date: Aug 2018 --> Aug 2017 Recruiting --> Active, not recruiting | Trial completion date: Jan 2018 --> Jun 2018 | Trial primary completion date: Jan 2018 --> Jun 2018
- | NN1213 / Novo Nordisk
Trial completion: Computerized DBT Skills Training for Suicidal and Heavy Episodic Drinkers (clinicaltrials.gov) - May 4, 2018
P=N/A, N=60, Completed, Sponsor: University of Washington
Recruiting --> Active, not recruiting | Trial completion date: Jan 2018 --> Jun 2018 | Trial primary completion date: Jan 2018 --> Jun 2018 Active, not recruiting --> Completed
- | Selincro (nalmefene oral) / Lundbeck, Acorda
Trial completion: USE-PACT: Use of Selincro and Impact on Usual Practice (clinicaltrials.gov) - May 4, 2018
P=N/A, N=698, Completed, Sponsor: University of Bordeaux
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: GIFTSS: College Health Center-based Alcohol and Sexual Violence Intervention (clinicaltrials.gov) - Apr 30, 2018
P=N/A, N=2295, Completed, Sponsor: University of Pittsburgh
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Trial completion date: An e-Parenting Skills Intervention to Decrease Injured Adolescents' Alcohol Use (clinicaltrials.gov) - Apr 11, 2018
P=N/A, N=36, Completed, Sponsor: Michael J. Mello, MD, MPH
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Nov 2017 --> Feb 2018
- | Phase classification: Self-Affirmation and Response to Health Risk Information (clinicaltrials.gov) - Apr 6, 2018
P, N=1116, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed | Trial completion date: Nov 2017 --> Feb 2018 Phase classification: P=N/A --> P
- | Phase classification: Self-Affirmation, Emotion, and Alcohol Consumption (clinicaltrials.gov) - Apr 5, 2018
P, N=690, Completed, Sponsor: National Cancer Institute (NCI)
Phase classification: P=N/A --> P Phase classification: P=N/A --> P
- | Trial completion date, Trial primary completion date: CTMI: A Randomized Clinical Trial of Culturally Tailored MI (clinicaltrials.gov) - Mar 30, 2018
P=N/A, N=301, Active, not recruiting, Sponsor: Northeastern University
Phase classification: P=N/A --> P Trial completion date: Nov 2017 --> Nov 2018 | Trial primary completion date: Nov 2017 --> Nov 2018
- | Trial completion, Phase classification: DO-SBIS: Disseminating Organizational SBI Services at Trauma Centers (clinicaltrials.gov) - Mar 7, 2018
P=N/A, N=878, Completed, Sponsor: University of Washington
Trial completion date: Nov 2017 --> Nov 2018 | Trial primary completion date: Nov 2017 --> Nov 2018 Recruiting --> Completed | Phase classification: P2 --> PN/A
- | Trial completion: Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients (clinicaltrials.gov) - Mar 1, 2018
P=N/A, N=614, Completed, Sponsor: University of California, San Francisco
Recruiting --> Completed | Phase classification: P2 --> PN/A Active, not recruiting --> Completed
- | sertraline / Generic mfg.
Enrollment change: Serotonin Selective Reuptake Inhibitor Treatment of Dual Diagnosis Post-traumatic Stress Disorder and Alcohol Problems (clinicaltrials.gov) - Feb 27, 2018
P4, N=49, Completed, Sponsor: The University of Texas Health Science Center at San Antonio
Active, not recruiting --> Completed N=142 --> 49
- | Trial completion, Enrollment change: Development and Evaluation of Effectiveness of an Internet-based Brief Intervention for Alcohol Use Among Brazilian College Students (clinicaltrials.gov) - Feb 12, 2018
P=N/A, N=46142, Completed, Sponsor: Federal University of S
N=142 --> 49 Active, not recruiting --> Completed | N=6500 --> 46142
- | Chantix (varenicline) / Pfizer
Trial completion, Enrollment change, Trial primary completion date: Do Treatments for Smoking Cessation Affect Alcohol Drinking? (clinicaltrials.gov) - Feb 7, 2018
P2, N=60, Completed, Sponsor: Yale University
Active, not recruiting --> Completed | N=6500 --> 46142 Active, not recruiting --> Completed | N=308 --> 60 | Trial primary completion date: Dec 2017 --> Nov 2016
- | Trial completion: An Open Label Trial of Bupropion and Naltrexone for Binge Drinking (clinicaltrials.gov) - Feb 1, 2018
P2, N=12, Completed, Sponsor: University of North Carolina, Chapel Hill
Active, not recruiting --> Completed | N=308 --> 60 | Trial primary completion date: Dec 2017 --> Nov 2016 Active, not recruiting --> Completed
- | Trial completion, Enrollment change, Trial primary completion date: CASPA: Alcohol Consumption and Stress at Patients Alcohol-dependants (clinicaltrials.gov) - Jan 26, 2018
P=N/A, N=42, Completed, Sponsor: Assistance Publique - H
Active, not recruiting --> Completed Recruiting --> Completed | N=140 --> 42 | Trial primary completion date: Aug 2016 --> Jul 2017
- | Trial completion: ALTAK: Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer (clinicaltrials.gov) - Jan 24, 2018
P=N/A, N=385, Completed, Sponsor: Centre Oscar Lambret
Recruiting --> Completed | N=140 --> 42 | Trial primary completion date: Aug 2016 --> Jul 2017 Terminated --> Completed
- | Trial completion: Community-Based Integrated Treatment for Adolescents (clinicaltrials.gov) - Jan 23, 2018
P1, N=114, Completed, Sponsor: Brown University
Terminated --> Completed Active, not recruiting --> Completed
- | Trial completion, Enrollment change: Engineering an Online STI Prevention Program (clinicaltrials.gov) - Jan 19, 2018
P=N/A, N=3997, Completed, Sponsor: Penn State University
Active, not recruiting --> Completed Recruiting --> Completed | N=13773 --> 3997
- | Enrollment closed, Enrollment change: RRFT: Integrative Risk Reduction and Treatment for Teen Substance Use Problems and PTSD (clinicaltrials.gov) - Jan 11, 2018
P=N/A, N=135, Active, not recruiting, Sponsor: Medical University of South Carolina
Recruiting --> Completed | N=13773 --> 3997 Recruiting --> Active, not recruiting | N=250 --> 135